Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome
NCT01104415
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Carcinoid Syndrome
Interventions
DRUG:
Telotristat etiprate
Sponsor
Lexicon Pharmaceuticals